Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

3-Deazaneplanocin,DZNep

Catalog No.
A1905
S-adenosylhomocysteine and EZH2 inhibitor
Grouped product items
SizePriceStock Qty
1mg
$150.00
In stock
5mg
$420.00
In stock
10mg
$596.00
In stock
25mg
$895.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

3-Deazaneplanocin (DZNep) (CAS No.102052-95-9) is an inhibitor of the enzyme S-adenosylhomocysteine hydrolase (SAHH), exerting its inhibitory activity via competitive interaction with adenosine. Its inhibition constant (Ki) against SAHH is approximately 0.05 nM. Additionally, 3-Deazaneplanocin suppresses the activity of histone methyltransferase EZH2. Studies in human leukemia HL-60 cells reported a moderate reduction of cellular proliferation at concentration of 10 μM. In hepatocellular carcinoma (HCC) cell lines (Huh1 and Huh7), treatment led to a dose-dependent inhibition in cell growth and reduced formation of non-adherent spheres. In vivo, the compound limited tumor initiation and growth in mouse xenograft models, suggesting utility in oncology research for targeting tumor-initiating cell populations.

References:

[1] Glazer R I, Hartman K D, Knode M C, et al. 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochemical and biophysical research communications, 1986, 135(2): 688-694.

[2] Chiba T, Suzuki E, Negishi M, et al. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells. International Journal of Cancer, 2012, 130(11): 2557-2567.

Product Citation

Chemical Properties

Physical AppearanceA crystalline solid
StorageStore at -20°C
M.Wt262.26
Cas No.102052-95-9
FormulaC12H24N4O3
SynonymsDZNep, 3-Deazaneplanocin A,NSC 617989,NSC617989
Solubilityinsoluble in EtOH; ≥17.07 mg/mL in DMSO; ≥17.43 mg/mL in H2O
Chemical Name(1S,2R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol
SDFDownload SDF
Canonical SMILESNc1nccc2c1nc[n]2[C@@H]([C@@H]1O)C=C(CO)[C@H]1O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment:[1]

Cell lines

Human acute myeloid leukemia (AML) cell

Preparation method

The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.

Reaction Conditions

100-750 nM; 24-72h

Applications

DZNep induced apoptosis in cultured and primary AML cells. DZNep exhausted EZH2 levels, and inhibits trimethylation of lysine 27 on histone H3 in the AML HL-60 and OCI-AML3 cells. DZNep induced the levels of p16, p21, p27, and FBXO32 after cyclin E and HOXA9 levels run out.

Animal experiment:[2]

Animal models

 

Sprague-Dawley rats (120–140 g)

Dosage form

 

5μM DZNep for 24 h pre-treatment before experiment, orally taken with diets

Applications

DZNep significantly reduced EZH2 expression and activity, and it increased lipid accumulation, inflammatory molecules and microRNAs in non-alcoholic fatty liver disease (NAFLD) mouse model.

Other notes

 

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

1. Fiskus W1, Wang Y, Sreekumar A et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009 Sep 24;114(13):2733-43.

2. Vella S, Gnani D, Crudele A et al. EZH2 down-regulation exacerbates lipid accumulation and inflammation in vitro and in vivo NAFLD.Int J Mol Sci. 2013 Dec 12;14(12):24154-68.

Biological Activity

Description 3-deazaneplanocin A (DZNeP), an analog of adenosine, is a competitive inhibitor of S-adenosylhomocysteine hydrolase with Ki of 50 pM.
Targets S-adenosylhomocysteine hydrolase          
IC50 50 pM (Ki)          

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep

Related Biological Data

3-Deazaneplanocin,DZNep